Jeff Geschwind, MD, is a key medical advisor for HistoSonics. He provides strategic guidance on their revolutionary, non-invasive sonic beam therapy for liver cancer, offering new hope to patients without surgical options. https://medicine.yale.edu/news/medicineatyale/article/two-clinical-leaders-join-medical-school-as-administrators/